Parietal epithelial cells (PECs) and PDs are derived from the same mesenchymal cells during embryogenesis (14-16); however, the expression level of miR193a determines the net phenotype-PECs vs. PDs-in these cells (17) . We have recently demonstrated that APOL1-miR193a axis preserves podocyte molecular phenotype in adverse milieus (18). We now hypothesize that APOL1 and miR193a forms a reciprocally linked feedback loop to regulate PECs' phenotype in humans. In this loop, lack of APOL1 assures PECs' phenotype while its presence initiates their transition to PDs.
APOL1 (G0) is a minor component of circulating lipid-rich trypanolytic multiprotein complexes in certain primate species including humans (1) . It is expressed in liver, pancreas, kidney, brain, macrophages, and endothelial cells (1) . Approximately 34% of African Americans carry one of the two risk variants (G1 and G2) and 13% have both variants (2, 3) . Increased expression of G1 and G2 risk variant APOL1, has been shown to induce cellular injury, including podocytes (PDs), both in vitro and in vivo (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) .
Parietal epithelial cells (PECs) and PDs are derived from the same mesenchymal cells during embryogenesis (14-16); however, the expression level of miR193a determines the net phenotype-PECs vs. PDs-in these cells (17) . We have recently demonstrated that APOL1-miR193a axis preserves podocyte molecular phenotype in adverse milieus (18) . We now hypothesize that APOL1 and miR193a forms a reciprocally linked feedback loop to regulate PECs' phenotype in humans. In this loop, lack of APOL1 assures PECs' phenotype while its presence initiates their transition to PDs.
APOL1 and miR193a are reciprocally linked with a feedback loop in PECs
PECs have not been shown to display expression of APOL1 both in vitro and in vivo studies (1, 19) . To examine the expression of APOL1, lysates of cultured PECs, differentiated PDs and HepG2 (positive control) and HEKs (negative control) were probed for APOL1 and GAPDH. HepG2s and PDs displayed robust expression of APOL1, but PECs and HEKs did not display any expression of APOL1 protein (Fig. 1A ).
Since APOL1 is expressed by PDs (1, 4, 19) , we asked whether PECs transiting to PDs' phenotype would also display APOL1. PECs were incubated in media for different time intervals followed by RNA and protein extractions. Protein blots were probed for APOL1 and GAPDH. PECs did not show expression of APOL1 protein on day 0, however, APOL1 expression emerged on day 4 and increased further during transition (Fig.1B) . RNAs were assayed for miR193a and cDNAs were amplified with an APOL1 specific primer. APOL1 mRNA expression increased (Fig. 1C ) but miR193a levels decreased (Fig. 1D ) during transition.
To evaluate a possible causal relationship, PECs were transfected with either scrambled or APOL1 siRNAs. cDNAs were amplified for APOL1 and RNAs were quantified for miR193. Down regulation of APOL1 mRNA (Lower panel, Fig. 1E ) was associated with an up regulation of miR193a (Upper panel, Fig. 1E ). These results suggest that PECs have a functional APOL1 protein which is not detectable by available tools; nonetheless, when knocked out up regulates miR193a expression.
For example a possible inverse relationship, PECs were transduced with vector or APOL1 (lentivirus). Protein and RNAs were extracted from Control (C ), vector (Vec) and APOL1-transduced PECs. cDNAs were amplified for APOL1 and RNAs were quantified for miR193a. An enhanced APOL1 expression (Lower panel) was associated with down regulation of miR193a expression (Upper panel) (Fig.1F ). APOL1-transduced PECs displayed enhanced APOL1 protein expression (data not shown).
If miR193a is also negatively regulating APOL1 gene expression then down regulation of miR193a should also de-repress APOL1 expression in PECs. miR193a expression in PECs was inhibited by a specific inhibitor and evaluated for APOL1 mRNA expression. Inhibition of miR193a expression enhanced APOL1 mRNA expression in PECs (Fig. 1G) .
To confirm the effect of miR193a inhibitor on APOL1 protein expression, PECs were transfected with either empty vector or miR193a inhibitor (n=3). Protein blots were probed for APOL1 and reprobed for GAPDH. Blots of three different lysates of control and experimental PECs are shown in Fig. 1H . miR193a inhibitor induced APOL1 protein expression in PECs.
To assess a possible APOL1-miR193a axis in non-kidney cells, HepG2s were treated with a miR193a inhibitor, followed by extraction of RNAs and assayed for miR193a as well as APOL1 mRNA. As shown in Fig. 1I , inhibition of miR193a in To confirm a reciprocal relationship between miR193a and APOL1 expression in HepG2s, cells were transfected with either empty vector (EV) or miR193a plasmids. cDNAs were amplified for APOL1 and RNAs were assessed for miR193a. Enhanced 
Both absence and presence of APOL1 characterize PECs' molecular profile
To characterize PECs' molecular phenotype, proteins and RNAs were extracted from control (cultured at 33°C) and Tr-PECs (PECs seeded on fibrin-coated plates for 4-14 days at 37°C). Protein blots were probed for several PEC and PD markers and reprobed for GAPDH (n=3). Representative gels (on 0 and 14 days) are displayed in Figs To determine the role of APOL1's (mRNA) absence in PECs' phenotype, we evaluated the effect of the silencing APOL1 mRNA on the expression of PEC markers.
PECs were transfected with either scrambled (SCR) or APOL1 siRNAs (n=3). Protein blots probed for PEC markers from three different lysates are displayed in Fig. 2J .
Cumulative data are shown in a bar diagram ( Since vitamin D has also been shown to down regulate miR193a expression in
PECs (17), we evaluated the effect of a VDR agonist on APOL1 induction in PECs.
PECs were treated with VDA and RNAs were evaluated for miR193a and APOL1. VDA not only down regulated miR193a expression ( In summary, both APOL1 and miR193a are reciprocally linked with a feedback loop in human PECs (Fig. 5L ). Up regulation of miR193a sustains the PEC phenotype through down regulation of APOL1 and WT1, whereas; down regulation of miR193a
initiates PECs' transition through up regulation of APOL1.
Methods

Human PECs, HEKs and HepG2s
Immortalized human PECs were initially obtained from Prof. Catherine MeyerSchwesinger, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
PECs were grown in 1:1 EGM endothelial growth medium supplemented with 5% FCS, 0.4% bovine brain extract, 0.1% hEGF, 0.1% hydrocortisone, 0.1% gentamicin and amphotericin B, 100 units/ml penicillin, 100 mg/ml streptomycin (Lonza, Basel, Switzerland), and RPMI 1640 supplemented with 10% FCS and 1× ITS at 33°C (5% Staining was visualized under a confocal microscope.
Immunofluorescence of kidney tissue
Human renal biopsy slides (control and HIVAN patients) and slides of renal cortical sections from FVB/N (control) and HIV: APOL1 transgenic (Tg26: APOL1) mice were placed into 100% xylene for 5 minutes for 4 times, then slides were placed into 100% ethanol for 5 minutes twice, then into 70% ethanol 5 minutes twice, then into 50% ethanol for 5 minutes twice. Slides were washed with ddH 2 O for 1 minute. Now slides were subjected into 1x retrieve-All antigen unmasking system buffer (Covance, Dedham) at 100 °C for 90 minutes. Slides were placed at room temperature for 20-30 minutes for cooling. Then washed with 1x PBS. Slides were subjected into 0.3% triton X-100 for 20 minutes at room temperature. Slides were blocked with 2% BSA for 2 hours. After blocking, primary antibody (cytokeratin at 1:50 dilution, synaptopodin at 1:50 dilution, and APOL1 at 1:100 dilution) were added for overnight at 4 °C. Next day, slides were washed with 0.1% triton X-100 for 5 minutes thrice on shaker at room temperature. Secondary antibody was added with fluorescence conjugated at 1:500 dilutions for 1 hour at room temperature. Nuclei were stained by DAPI. Slides were washed with 0.1% triton X-100 for 5 minutes thrice on shaker at room temperature and mounted for confocal microscopy. Relative quantification of gene expression was calculated using the ΔΔCT method.
Western Blot Analysis and Antibodies
Protein blots of control and experimental cells were performed as previously described (4) . Briefly, protein lysates were prepared using RIPA lysis buffer (Millipore, USA). After boiling for 15 minutes, equal volume of cell lysates were electrophoresed using 10-12%
of SDS-PAGE gels. Separated proteins were transferred to PVDF (EMD Millipore) 
Statistical analyses
Statistical comparisons were performed with the program PRISM using the MannWhitney U test for nonparametric data and the unpaired t test for parametric data.
A P value<0.05 was accepted as statistically significant. 
